Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
Study Identifier
P19-377
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
Study Locations
Location
Status
Location
Emiliano Baccarini Priv Practice /ID# 218581
Lomas de Zamora, Buenos Aires, Argentina, 1832
Status
Not applicable
Location
Hospital Universitario Austral /ID# 217540
Pilar, Buenos Aires, Argentina, 1629
Status
Not applicable
Location
Stringa Dermatologia /ID# 218450
Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina, 1114
Status
Not applicable
Location
Private Office Cristina Echeverria /ID# 222082
Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina, 1425
Status
Not applicable
Location
Stat Research /ID# 217185
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1023
Status
Not applicable
Location
Buenos Aires Skin /ID# 217657
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1055
Status
Not applicable
Showing {first} - {last} of {total} Results